Though the studies of KAT2A‐mediated histone succinylation at lysine residues in the nucleus are at an early stage, specific data demonstrate that it may be a crucial part in the development of diseases such as tumours, human pancreatic ductal adenocarcinoma (PDAC) and hepatitis B virus. The gene discussed is KAT2A; the disease is neoplasm.